Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

FAPI

  • Localized In Vivo Prodrug Activation Using Radionuclides
    Open Access
    Localized In Vivo Prodrug Activation Using Radionuclides
    Jeremy M. Quintana, Fangchao Jiang, Mikyung Kang, Victor Valladolid Onecha, Arda Könik, Lei Qin, Victoria E. Rodriguez, Huiyu Hu, Nicholas Borges, Ishaan Khurana, Leou I. Banla, Mariane Le Fur, Peter Caravan, Jan Schuemann, Alejandro Bertolet, Ralph Weissleder, Miles A. Miller and Thomas S.C. Ng
    Journal of Nuclear Medicine January 1, 2025, 66 (1) 91-97; DOI: https://doi.org/10.2967/jnumed.124.268559
  • Feasibility, Tolerability, and Preliminary Clinical Response of Fractionated Radiopharmaceutical Therapy with <sup>213</sup>Bi-FAPI-46: Pilot Experience in Patients with End-Stage, Progressive Metastatic Tumors
    You have access
    Feasibility, Tolerability, and Preliminary Clinical Response of Fractionated Radiopharmaceutical Therapy with 213Bi-FAPI-46: Pilot Experience in Patients with End-Stage, Progressive Metastatic Tumors
    Andreas Helisch, Clemens Kratochwil, Christian Kleist, Susanne Krämer, Juan Jose Rosales Castillo, Katharina Dendl, Hendrik Rathke, Isabelle von Goetze, Mathias Schreckenberger, Dirk Jäger, Thomas Lindner, Walter Mier, Frederik Giesel, Uwe Haberkorn and Manuel Röhrich
    Journal of Nuclear Medicine December 1, 2024, 65 (12) 1917-1922; DOI: https://doi.org/10.2967/jnumed.124.268386
  • FAP and PSMA Expression by Immunohistochemistry and PET Imaging in Castration-Resistant Prostate Cancer: A Translational Pilot Study
    You have access
    FAP and PSMA Expression by Immunohistochemistry and PET Imaging in Castration-Resistant Prostate Cancer: A Translational Pilot Study
    Rong Rong Huang, Chunlai Zuo, Christine E. Mona, Adrien Holzgreve, Colm Morrissey, Peter S. Nelson, Lauren Brady, Lawrence True, Anthony Sisk, Johannes Czernin, Jeremie Calais and Huihui Ye
    Journal of Nuclear Medicine December 1, 2024, 65 (12) 1952-1958; DOI: https://doi.org/10.2967/jnumed.124.268037
  • [<sup>18</sup>F]AlF-NOTA-FAPI-04 PET/CT for Predicting Pathologic Response of Resectable Esophageal Squamous Cell Carcinoma to Neoadjuvant Camrelizumab and Chemotherapy: A Phase II Clinical Trial
    You have access
    [18F]AlF-NOTA-FAPI-04 PET/CT for Predicting Pathologic Response of Resectable Esophageal Squamous Cell Carcinoma to Neoadjuvant Camrelizumab and Chemotherapy: A Phase II Clinical Trial
    Yinjun Dong, Zhendan Wang, Xinying Hu, Yuhong Sun, Jingjie Qin, Qiming Qin, Shuguang Liu, Shuanghu Yuan, Jinming Yu and Yuchun Wei
    Journal of Nuclear Medicine November 1, 2024, 65 (11) 1702-1709; DOI: https://doi.org/10.2967/jnumed.124.268557
  • Correlation of FAPI PET Uptake with Immunohistochemistry in Explanted Lungs from Patients with Advanced Interstitial Lung Disease
    You have access
    Correlation of FAPI PET Uptake with Immunohistochemistry in Explanted Lungs from Patients with Advanced Interstitial Lung Disease
    Masatoshi Hotta, Grace Hyun J. Kim, Vilasinee Rerkpichaisuth, Pang Yu Teng, Wesley R. Armstrong, Giuseppe Carlucci, Magnus Dahlbom, Fereidoun Abtin, Shahrzad M. Lari, Gregory A. Fishbein, Johannes Czernin, Elizabeth R. Volkmann, S. Sam Weigt and Jeremie Calais
    Journal of Nuclear Medicine November 1, 2024, 65 (11) 1789-1794; DOI: https://doi.org/10.2967/jnumed.124.268351
  • Fibroblast Activation Protein–Directed Imaging Outperforms <sup>18</sup>F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial
    You have access
    Fibroblast Activation Protein–Directed Imaging Outperforms 18F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial
    Lukas Kessler, Felix Schwaning, Martin Metzenmacher, Kim Pabst, Jens Siveke, Marija Trajkovic-Arsic, Benedikt Schaarschmidt, Marcel Wiesweg, Clemens Aigner, Till Plönes, Kaid Darwiche, Servet Bölükbas, Martin Stuschke, Lale Umutlu, Michael Nader, Dirk Theegarten, Rainer Hamacher, Wilfried E.E. Eberhardt, Martin Schuler, Ken Herrmann, Wolfgang P. Fendler and Hubertus Hautzel
    Journal of Nuclear Medicine August 1, 2024, 65 (8) 1188-1193; DOI: https://doi.org/10.2967/jnumed.124.267473
  • Diagnostic Potential of Supplemental Static and Dynamic <sup>68</sup>Ga-FAPI-46 PET for Primary <sup>18</sup>F-FDG–Negative Pulmonary Lesions
    You have access
    Diagnostic Potential of Supplemental Static and Dynamic 68Ga-FAPI-46 PET for Primary 18F-FDG–Negative Pulmonary Lesions
    Manuel Röhrich, Johanna Daum, Ewgenija Gutjahr, Anna-Maria Spektor, Frederik M. Glatting, Yasemin Aylin Sahin, Hans Georg Buchholz, Jorge Hoppner, Cathrin Schroeter, Eleni Mavriopoulou, Kai Schlamp, Matthias Grott, Florian Eichhorn, Claus Peter Heußel, Hans Ulrich Kauczor, Michael Kreuter, Frederik Giesel, Mathias Schreckenberger, Hauke Winter and Uwe Haberkorn
    Journal of Nuclear Medicine June 1, 2024, 65 (6) 872-879; DOI: https://doi.org/10.2967/jnumed.123.267103
  • Diagnostic Accuracy of <sup>68</sup>Ga-FAPI Versus <sup>18</sup>F-FDG PET in Patients with Various Malignancies
    You have access
    Diagnostic Accuracy of 68Ga-FAPI Versus 18F-FDG PET in Patients with Various Malignancies
    Nader Hirmas, Rainer Hamacher, Miriam Sraieb, Lukas Kessler, Kim M. Pabst, Francesco Barbato, Helena Lanzafame, Stefan Kasper, Michael Nader, Claudia Kesch, Bastian von Tresckow, Hubertus Hautzel, Clemens Aigner, Martin Glas, Martin Stuschke, Sherko Kümmel, Philipp Harter, Celine Lugnier, Waldemar Uhl, Boris Hadaschik, Viktor Grünwald, Jens T. Siveke, Ken Herrmann and Wolfgang P. Fendler
    Journal of Nuclear Medicine March 1, 2024, 65 (3) 372-378; DOI: https://doi.org/10.2967/jnumed.123.266652
  • Fibroblast Activation Protein α–Directed Imaging and Therapy of Solitary Fibrous Tumor
    You have access
    Fibroblast Activation Protein α–Directed Imaging and Therapy of Solitary Fibrous Tumor
    Rainer Hamacher, Kim M. Pabst, Phyllis F. Cheung, Christoph E. Heilig, Jennifer Hüllein, Sven-Thorsten Liffers, Sabrina Borchert, Pedro Fragoso Costa, Benedikt M. Schaarschmidt, Lukas Kessler, Monika A. Miera, Margret Droste, Merve Akbulut, Johanna Falkenhorst, Fadi Zarrad, Karina Kostbade, Ilektra A. Mavroeidi, Hanno Glimm, Lale Umutlu, Martin Schuler, Daniel Hübschmann, Sebastian Bauer, Stefan Fröhling, Ken Herrmann, Jens T. Siveke, Hans-Ulrich Schildhaus and Wolfgang P. Fendler
    Journal of Nuclear Medicine February 1, 2024, 65 (2) 252-257; DOI: https://doi.org/10.2967/jnumed.123.266411
  • Immunohistochemical FAP Expression Reflects <sup>68</sup>Ga-FAPI PET Imaging Properties of Low- and High-Grade Intraductal Papillary Mucinous Neoplasms and Pancreatic Ductal Adenocarcinoma
    You have access
    Immunohistochemical FAP Expression Reflects 68Ga-FAPI PET Imaging Properties of Low- and High-Grade Intraductal Papillary Mucinous Neoplasms and Pancreatic Ductal Adenocarcinoma
    Anna-Maria Spektor, Ewgenija Gutjahr, Matthias Lang, Frederik M. Glatting, Thilo Hackert, Thomas Pausch, Christine Tjaden, Mathias Schreckenberger, Uwe Haberkorn and Manuel Röhrich
    Journal of Nuclear Medicine January 1, 2024, 65 (1) 52-58; DOI: https://doi.org/10.2967/jnumed.123.266393

Pages

  • Next
  • 1
  • 2
  • 3
SNMMI

© 2025 SNMMI

Powered by HighWire